COVID-19 Therapeutics Task Force

The COVID-19 Therapeutics Task Force was a Canadian public-private advisory body convened by Innovation, Science and Economic Development Canada (ISED).1)

History

Navdeep Bains, Minister of Innovation, Science and Industry, announced the membership of the COVID-19 Therapeutics Task Force on August 5, 2020.2) Bains also announced the membership of the COVID-19 Vaccine Task Force.

Members

Members
Name Position Affiliation(s)
Nancy Harrison Co-chair Life Sciences British Columbia, Ventures West, MSI Methylation Sciences, Creative Destruction Lab, adMare BioInnovations, Digital Technology Supercluster, Genome British Columbia, Knight Therapeutics
Cédric Bisson Co-chair Teralys Capital, iNovia Capital, McKinsey & Company, Montreal InVivo, Grand Challenges Canada, Procure
Maha Katabi Member Sofinnova, Amplyx Pharmaceuticals, Northsea Therapeutics, Oxalis Capital, Sectoral Asset Management, Ventures West Management, T2C2 Capital, Exactis Innovation
Gordon McCauley Member adMare BioInnovations, Viable Healthworks, Allon Therapeutics, NDI Cpaital, BIOTECanada, CGen, Life Sciences British Columbia, Biotechnology Innovation Organization (BIO), Acetech, Toronto Rehabilitation Institute, Toronto Rehab Foundation
Parimal Nathwani Member Toronto Innovation Acceleration Partners (TIAP), MaRS Discovery District, UBC University Industry Liaison Office (UILO), TRIUMF Innovations, Zucara Therapeutics, Vasomune Therapeutics, Encycle Therapeutics
Ali Tehrani Member Zymeworks, Student Biotechnology Network (SBN), Consortium de recherche biopharmaceutique (CQDM), Life Sciences British Columbia, Mitacs, BIOTECanada, Premier's Technology Council, Creatus Biosciences
Youla Tsantrizos Member McGill University, Boehringer Ingelheim, Centre de recherche en biologie structurale (CRBS), Canadian Society for Chemistry, Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Institutes of Health Research (CIHR), Ontario Institute for Cancer Research (OICR)
Advisors
Lisa Barrett Advisor Dalhousie University, Senescence Aging Infection & Immunity Lab (SAIL), National Institute of Allergy and Infectious Diseases (NIAID)
Marceline Côté Advisor University of Ottawa
Eleanor Fish Advisor University of Toronto, University Health Network (UHN)
Matthias Götte Advisor Li Ka Shing Institute of Virology, McGill University
François Jean Advisor Facility for Infectious Disease and Epidemic Research (FINDER)
Samira Mubareka Advisor Sunnybrook Health Sciences Centre, University of Toronto, Centre for Research Expertise in Occupational Disease (CREOD), Canadian COVID-19 Genomics Network (CanCOGen), Genome Canada, Ontario's COVID-19 Genomics Rapid Response Coalition (ONCoV), Ontario Academic Health Sciences SARS-CoV-2 Sequencing Network (ONS2), Sunnybrook Translational Research Group for Emerging Respiratory Viruses (SERV)
Pamela Ohashi Advisor Princess Margaret Cancer Centre, University of Toronto, American Association for Cancer Research (AACR), Society for Immunotherapy of Cancer (SITC), Royal Society of Canada (RSC)
James Russell Advisor University of British Columbia (UBC), Centre for Heart Lung Innovation (HLI), Sirius Genomics, Cyon Therapeutics, St. Paul's Hospital
Makeda Semret Advisor McGill University Health Centre (MUHC), Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), AAU-McGill Partnership for Infectious Diseases (AMP-ID)
Don Sheppard Advisor McGill University Health Centre (MUHC), McGill Interdisciplinary Initiative in Infection and Immunity (MI4)
Don Vinh Advisor McGill University Health Centre (MUHC), Canadian Glycomics Network (GlycoNet), Association of Medical Microbiology and Infectious Disease Canada (AMMI), Clinical Immunology Society (CIS), Comité consultatif québécois pour les maladies rares, MUHC COVID-19 Biobank, COVID-19 and Cancer Consortium (CCC19), COVID Human Genetic Effort (CHGE)
1)
Innovation, Science and Economic Development Canada. (2022, March 10). COVID-19 Therapeutics Task Force. Government of Canada. http://archive.today/2023.04.27-230206/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force
2)
Jagric, A., Roy, C., Innovation, Science and Economic Development Canada, & Public Services and Procurement Canada. (2020, August 5). Government of Canada announces major steps in treating and preventing COVID-19 through vaccines and therapies. Government of Canada. http://archive.today/2022.12.16-235932/https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html
Back to top